PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+2.78%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$809M
AUM Growth
+$809M
(-29%)
Cap. Flow
-$228M
Cap. Flow
% of AUM
-28.17%
Top 10 Holdings %
Top 10 Hldgs %
58.32%
Holding
147
New
42
Increased
27
Reduced
25
Closed
33
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$26.7M |
| 2 |
CELG
Celgene Corp
CELG
|
$24.4M |
| 3 |
MacroGenics
MGNX
|
$19.7M |
| 4 |
AbbVie
ABBV
|
$18.5M |
| 5 |
MannKind Corp
MNKD
|
$18.3M |
Top Sells
| 1 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$133M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$69.5M |
| 3 |
Gilead Sciences
GILD
|
$61.2M |
| 4 |
RPRX
Repros Therapeutics Inc.
RPRX
|
$25.8M |
| 5 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$21.8M |
Sector Composition
| 1 | Healthcare | 87.52% |
| 2 | Consumer Discretionary | 0.05% |
| 3 | Industrials | 0.03% |
| 4 | Consumer Staples | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Lisata Therapeutics
LSTA
$19.9M
| $1.57M | 0.19% | 229,593 -102,000 | -31% | -$696K |
|
52
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.5M | 0.18% | 197,500 +6,912 | +4% | +$52.5K |
|
|
SNTS
53
DELISTED
SANTARUS INC
SNTS
| $1.45M | 0.17% | 45,400 -486,843 | -91% | -$15.6M |
|
|
SHPG
54
DELISTED
Shire pic
SHPG
| $1.41M | 0.17% | +10,000 | New | +$1.41M |
|
|
ANTH
55
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $1.33M | 0.16% | 431,456 | – | – |
|
|
RPRX
56
DELISTED
Repros Therapeutics Inc.
RPRX
| $1.32M | 0.16% | 71,879 -1,409,854 | -95% | -$25.8M |
|
57
DexCom
DXCM
$29.5B
| $1.06M | 0.13% | 30,000 -42,550 | -59% | -$1.51M |
|
|
TBIO
58
DELISTED
TRANGSGENOMIC INC
TBIO
| $1M | 0.12% | 2,207,500 | – | – |
|
59
Curis
CRIS
$20.9M
| $987K | 0.12% | +350,000 | New | +$987K |
|
|
CASC
60
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $880K | 0.11% | 500,000 +17,500 | +4% | +$30.8K |
|
61
MiMedx Group
MDXG
$1.05B
| $874K | 0.11% | +100,000 | New | +$874K |
|
|
UPI
62
DELISTED
UROPLASTY INC-NEW
UPI
| $857K | 0.1% | 313,989 +10,000 | +3% | +$27.3K |
|
63
United Therapeutics
UTHR
$13.8B
| $792K | 0.1% | +7,000 | New | +$792K |
|
|
SCAI
64
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $697K | 0.08% | +20,000 | New | +$697K |
|
|
NSPH
65
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $676K | 0.08% | 295,000 -44,500 | -13% | -$102K |
|
|
BLUE
66
DELISTED
bluebird bio
BLUE
| $420K | 0.05% | +20,000 | New | +$420K |
|
|
DS
67
DELISTED
Drive Shack Inc.
DS
| $402K | 0.05% | +70,000 | New | +$402K |
|
|
GNMX
68
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $367K | 0.04% | 61,263 -88,737 | -59% | -$532K |
|
69
Microbot Medical
MBOT
$185M
| $334K | 0.04% | 271,600 +40,000 | +17% | +$49.2K |
|
|
XNPT
70
DELISTED
XENOPORT, INC.
XNPT
| $288K | 0.03% | 50,000 +1,750 | +4% | +$10.1K |
|
|
CUTR
71
DELISTED
Cutera, Inc.
CUTR
| $228K | 0.03% | 22,400 +10,000 | +81% | +$102K |
|
|
LCI
72
DELISTED
Lannett Company, Inc.
LCI
| $223K | 0.03% | +6,744 | New | +$223K |
|
73
Illumina
ILMN
$15.8B
| $221K | 0.03% | +2,000 | New | +$221K |
|
|
INSY
74
DELISTED
Insys Therapeutics, Inc.
INSY
| $221K | 0.03% | +5,722 | New | +$221K |
|
|
MDSO
75
DELISTED
Medidata Solutions, Inc.
MDSO
| $220K | 0.03% | +3,642 | New | +$220K |
|